However, because IKs blockage contributes to long‐QT syndrome,34 more extensive studies are needed to investigate the safety profiles of VEGF in the treatment of arrhythmia and ischemic heart disease. The gene discussed is VEGFA; the disease is cardiac arrhythmia.